Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

OCX

Company AnnouncementsOncoCyte Rebrands to Insight Molecular Diagnostics

12d ago

OCX

PremiumThe Fly

OncoCyte changes name to Insight Molecular Diagnostics

12d ago

OCX

PremiumThe Fly

Needham medtech & diagnostics analyst holds analyst/industry conference call

1M ago

OCX

BLDE

PremiumThe Fly

OncoCyte reports Medicare boosts reimbursement for GraftAssureCore

1M ago

OCX

PremiumThe Fly

OncoCyte price target raised to $8 from $5 at Lake Street

1M ago

OCX

PremiumCompany AnnouncementsOncoCyte Corp’s Earnings Call: Optimism Amid Challenges

1M ago

OCX

OncoCyte’s Strategic Initiatives and Financial Management Drive Buy Rating

Premium

Ratings

OncoCyte’s Strategic Initiatives and Financial Management Drive Buy Rating

2M ago

OCX

OncoCyte Corp Reports Revenue Growth Amid Losses

Premium

Company Announcements

OncoCyte Corp Reports Revenue Growth Amid Losses

2M ago

OCX

PremiumPre-Earnings

OCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?

2M ago

OCX

PremiumThe Fly

OncoCyte provides update on progress toward initiating clinical trial

2M ago

OCX

PremiumThe Fly

OncoCyte announces new publication on transplant rejection assay

2M ago

OCX

PremiumRatings

OncoCyte Positioned for Growth: Buy Rating Affirmed by Michael Matson

3M ago

OCX

PremiumThe FlyOncoCyte files to sell 10.61M shares of common stock for holders

3M ago

OCX

OncoCyte’s Strategic Positioning and Growth Potential in Transplant Rejection Testing

Premium

Ratings

OncoCyte’s Strategic Positioning and Growth Potential in Transplant Rejection Testing

3M ago

OCX

OncoCyte initiated with a Buy at Lake Street

Premium

The Fly

OncoCyte initiated with a Buy at Lake Street

3M ago

OCX

PremiumCompany Announcements

OncoCyte Corp’s Positive Earnings Call Highlights Growth

3M ago

OCX

PremiumThe Fly

OncoCyte reports Q4 EPS ($1.93) vs. ($1.96) last year

3M ago

OCX

PremiumRatings

Positive Outlook on OncoCyte’s Stock Due to Strategic Launch and Financial Management

3M ago

OCX

PremiumCompany Announcements

Oncocyte Corp Reports 2024 Success and 2025 Growth Plans

3M ago

OCX

PremiumPre-EarningsOCX Upcoming Earnings Report: What to Expect?

3M ago

OCX

OncoCyte Announces Executive Promotions and Compensation Changes

Premium

Company Announcements

OncoCyte Announces Executive Promotions and Compensation Changes

4M ago

OCX

OncoCyte’s $29.1M Funding Through Securities Agreements

Premium

Company Announcements

OncoCyte’s $29.1M Funding Through Securities Agreements

5M ago

OCX

OCX

Trending

Indices

Stocks

ETFs